{"title": "Forecasting ultra-early intensive care strain from COVID-19 in England", "doi": "10.1101/2020.03.19.20039057", "citation_id": "2020.03.19.20039057v1", "date": "2020-03-23", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.19.20039057", "abstract": "<p>The COVID-19 pandemic has led to unprecedented strain on intensive care unit (ICU) admission in parts of the world. Strategies to create surge ICU capacity requires complex local and national service reconfiguration and reduction or cancellation of elective activity. Theses measures require time to implement and have an inevitable lag before additional capacity comes on-line. An accurate short-range forecast would be helpful in guiding such difficult, costly and ethically challenging decisions.\n\nAt the time this work began, cases in England were starting to increase. Here we present an attempt at an agile short-range forecast based on published real-time COVID-19 case data from the seven National Health Service commissioning regions in England (East of England, London, Midlands, North East and Yorkshire, North West, South East and South West). We use a Monte Carlo approach to model the likely impact of current diagnoses on regional ICU capacity over a 14 day horizon. Our model is designed to be parsimonious and based on plausible epidemiological data from the literature available.\n\nOn the basis of the modelling assumptions made, ICU occupancy is likely to increase dramatically in the the days following the time of modelling. If the current exponential growth continues, 5 out of 7 commissioning regions will have more critically ill COVID-19 patients than there are ICU beds within two weeks\\todo{last thing to do}. Despite variable growth in absolute patients, all commissioning regions are forecast to be heavily burdened under the assumptions used.\n\nWhilst, like any forecast model, there remain uncertainties both in terms of model specification and robust epidemiological data in this early prospective phase, it would seem that surge capacity will be required in the very near future. We hope that our model will help policy decision makers with their preparations. The uncertainties in the data highlight the urgent need for ongoing real-time surveillance to allow forecasts to be constantly updated using high quality local patient-facing data as it emerges.</p>", "twitter_description": "The COVID-19 pandemic has led to unprecedented strain on intensive care unit (ICU) admission in parts of the world. Strategies to create surge ICU capacity requires complex local and national service reconfiguration and reduction or cancellation of elective activity. Theses measures require time to implement and have an inevitable lag before additional capacity comes on-line. An accurate short-range forecast would be helpful in guiding such difficult, costly and ethically challenging decisions. At the time this work began, cases in England were starting to increase. Here we present an attempt at an agile short-range forecast based on published real-time COVID-19 case data from the seven National Health Service commissioning regions in England (East of England, London, Midlands, North East and Yorkshire, North West, South East and South West). We use a Monte Carlo approach to model the likely impact of current diagnoses on regional ICU capacity over a 14 day horizon. Our model is designed to be parsimonious and based on plausible epidemiological data from the literature available. On the basis of the modelling assumptions made, ICU occupancy is likely to increase dramatically in the the days following the time of modelling. If the current exponential growth continues, 5 out of 7 commissioning regions will have more critically ill COVID-19 patients than there are ICU beds within two weeks\\todo{last thing to do}. Despite variable growth in absolute patients, all commissioning regions are forecast to be heavily burdened under the assumptions used. Whilst, like any forecast model, there remain uncertainties both in terms of model specification and robust epidemiological data in this early prospective phase, it would seem that surge capacity will be required in the very near future. We hope that our model will help policy decision makers with their preparations. The uncertainties in the data highlight the urgent need for ongoing real-time surveillance to allow forecasts to be constantly updated using high quality local patient-facing data as it emerges.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNot externally funded\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nSource data is already publicly available.\n\n<https://zenodo.org/badge/latestdoi/131309845>", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.19.20039057v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.19.20039057v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.19.20039057v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/23/2020.03.19.20039057.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at http://creativecommons.org/licenses/by/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.19.20039057v1", "access_rights": "restricted", "authors": ["Jacob Deasy", "Emma Rocheteau", "Katharina Kohler", "Daniel J. Stubbs", "Peitro Barbiero", "Pietro Li\u00f2", "Ari Ercole"]}